Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genetic and Functional Profiling of CD16-Dependent Natural Killer Activation Identifies Patients at Higher Risk of Cardiac Allograft Vasculopathy.
Paul P, Picard C, Sampol E, Lyonnet L, Di Cristofaro J, Paul-Delvaux L, Lano G, Nicolino-Brunet C, Ravis E, Collart F, Dignat-George F, Dussol B, Sabatier F, Mouly-Bandini A. Paul P, et al. Among authors: nicolino brunet c. Circulation. 2018 Mar 6;137(10):1049-1059. doi: 10.1161/CIRCULATIONAHA.117.030435. Epub 2017 Nov 2. Circulation. 2018. PMID: 29097449
Antibody-Dependent NK Cell Activation Is Associated with Late Kidney Allograft Dysfunction and the Complement-Independent Alloreactive Potential of Donor-Specific Antibodies.
Legris T, Picard C, Todorova D, Lyonnet L, Laporte C, Dumoulin C, Nicolino-Brunet C, Daniel L, Loundou A, Morange S, Bataille S, Vacher-Coponat H, Moal V, Berland Y, Dignat-George F, Burtey S, Paul P. Legris T, et al. Among authors: nicolino brunet c. Front Immunol. 2016 Aug 11;7:288. doi: 10.3389/fimmu.2016.00288. eCollection 2016. Front Immunol. 2016. PMID: 27563301 Free PMC article.
Cancer risk in HIV-infected patients: elite controllers are also concerned.
Poizot-Martin I, Laroche H, Cano CE, Nicolino-Brunet C, Zaegel-Faucher O, Bregigeon S, Tamalet C, Dignat-George F. Poizot-Martin I, et al. Among authors: nicolino brunet c. AIDS. 2018 Mar 13;32(5):673-675. doi: 10.1097/QAD.0000000000001736. AIDS. 2018. PMID: 29494425 No abstract available.
Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial.
Loret EP, Darque A, Jouve E, Loret EA, Nicolino-Brunet C, Morange S, Castanier E, Casanova J, Caloustian C, Bornet C, Coussirou J, Boussetta J, Couallier V, Blin O, Dussol B, Ravaux I. Loret EP, et al. Retrovirology. 2016 Apr 1;13:21. doi: 10.1186/s12977-016-0251-3. Retrovirology. 2016. PMID: 27036656 Free PMC article. Clinical Trial.
Erratum to: Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial.
Loret EP, Darque A, Jouve E, Loret EA, Nicolino-Brunet C, Morange S, Castanier E, Casanova J, Caloustian C, Bornet C, Coussirou J, Boussetta J, Couallier V, Blin O, Dussol B, Ravaux I. Loret EP, et al. Retrovirology. 2016 May 9;13(1):35. doi: 10.1186/s12977-016-0264-y. Retrovirology. 2016. PMID: 27160192 Free PMC article. No abstract available.
HIV protease inhibitors do not cause the accumulation of prelamin A in PBMCs from patients receiving first line therapy: the ANRS EP45 "aging" study.
Perrin S, Cremer J, Faucher O, Reynes J, Dellamonica P, Micallef J, Solas C, Lacarelle B, Stretti C, Kaspi E, Robaglia-Schlupp A, Nicolino-Brunet C, Tamalet C, Lévy N, Poizot-Martin I, Cau P, Roll P. Perrin S, et al. PLoS One. 2012;7(12):e53035. doi: 10.1371/journal.pone.0053035. Epub 2012 Dec 28. PLoS One. 2012. PMID: 23285253 Free PMC article. Clinical Trial.
19 results